Danielle Brill
Stock Analyst at Truist Securities
(0.73)
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
IRON Disc Medicine | Initiates Coverage On: Buy | 86 | 58.61 | 46.73% | 6 | Jul 21, 2025 | |
ALNY Alnylam Pharmaceutic... | Initiates Coverage On: Buy | 385 | 434.89 | -11.47% | 1 | Jul 21, 2025 | |
HRMY Harmony Biosciences ... | Initiates Coverage On: Buy | 48 | 34.83 | 37.81% | 8 | Jul 21, 2025 | |
PVLA Palvella Therapeutic... | Initiates Coverage On: Buy | 56 | 41.54 | 34.81% | 1 | Jul 21, 2025 | |
TECX Tectonic Therapeutic | Initiates Coverage On: Buy | 64 | 22.01 | 190.78% | 2 | Jul 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 163 | 123.99 | 31.46% | 6 | Jul 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 66 | 48.24 | 36.82% | 1 | Jul 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 30 | 16.6 | 80.72% | 1 | Jul 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 24 | 17.51 | 37.06% | 1 | Jul 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Strong Buy | 20 52 | 14.13 | 268.01% | 6 | Dec 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 1 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 79 | 56.8 | 39.08% | 1 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 18 | 7.46 | 141.29% | 1 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 36 | 14.76 | 143.9% | 4 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 150 | 17.95 | 735.65% | 3 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 2 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 2 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 2 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Strong Buy | 605 | 638.76 | -5.29% | 7 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Market Perform | n/a | n/a | n/a | 5 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 50 | 34.12 | 46.54% | 2 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 51 | 35.1 | 45.3% | 2 | Oct 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 180 100 | 5.92 | 1589.19% | 5 | Nov 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | n/a | n/a | n/a | 9 | Sep 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 5 | Jun 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 3 | Oct 4, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 75 50 | n/a | n/a | 5 | Jan 20, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | n/a | n/a | n/a | 1 | Aug 25, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | n/a | n/a | n/a | 1 | Aug 25, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 3 | Sep 17, 2019 |